Literature DB >> 26464332

'(De-)sensitization' vs. 'Uncoupling': what drives cardiomyopathies in the thin filament? Reply.

Steven Marston1, Andrew Messer2, Maria Papadaki2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26464332      PMCID： PMC4888944          DOI： 10.1093/cvr/cvv233

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  10 in total

1.  Structure of the C-domain of human cardiac troponin C in complex with the Ca2+ sensitizing drug EMD 57033.

Authors:  X Wang; M X Li; L Spyracopoulos; N Beier; M Chandra; R J Solaro; B D Sykes
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

Review 2.  The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation.

Authors:  R John Solaro; Paul Rosevear; Tomoyoshi Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

Review 3.  How do mutations in contractile proteins cause the primary familial cardiomyopathies?

Authors:  Steven B Marston
Journal:  J Cardiovasc Transl Res       Date:  2011-03-22       Impact factor: 4.132

4.  Phosphorylation-dependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin.

Authors:  Jack W Howarth; Jarek Meller; R John Solaro; Jill Trewhella; Paul R Rosevear
Journal:  J Mol Biol       Date:  2007-08-22       Impact factor: 5.469

5.  The cardiac-specific N-terminal region of troponin I positions the regulatory domain of troponin C.

Authors:  Peter M Hwang; Fangze Cai; Sandra E Pineda-Sanabria; David C Corson; Brian D Sykes
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

6.  Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies.

Authors:  Olga K Baryshnikova; Monica X Li; Brian D Sykes
Journal:  J Mol Biol       Date:  2007-11-01       Impact factor: 5.469

7.  Solution structure of human cardiac troponin C in complex with the green tea polyphenol, (-)-epigallocatechin 3-gallate.

Authors:  Ian M Robertson; Monica X Li; Brian D Sykes
Journal:  J Biol Chem       Date:  2009-06-20       Impact factor: 5.157

8.  Characterization of the interaction between the N-terminal extension of human cardiac troponin I and troponin C.

Authors:  Douglas G Ward; Susan M Brewer; Melanie J Calvert; Clare E Gallon; Yuan Gao; Ian P Trayer
Journal:  Biochemistry       Date:  2004-04-06       Impact factor: 3.162

9.  The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin I.

Authors:  Petr G Vikhorev; Weihua Song; Ross Wilkinson; O'Neal Copeland; Andrew E Messer; Michael A Ferenczi; Steven B Marston
Journal:  Biophys J       Date:  2014-11-18       Impact factor: 4.033

Review 10.  Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy.

Authors:  Andrew E Messer; Steven B Marston
Journal:  Front Physiol       Date:  2014-08-25       Impact factor: 4.566
  10 in total
  1 in total

Review 1.  The Importance of Intrinsically Disordered Segments of Cardiac Troponin in Modulating Function by Phosphorylation and Disease-Causing Mutations.

Authors:  Maria Papadaki; Steven B Marston
Journal:  Front Physiol       Date:  2016-11-02       Impact factor: 4.566
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.